Amble logo

Amble Review

7.5
★★★★☆3.8/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10

Best for: flat-price compounded GLP-1 with free shipping and discounts for 3- or 6-month plans

Amble scores highest on state availability and ease of access.

Offer28%Off 1st mo

Amble discount & current deal

Semaglutide$129/mo was$179

First month, then $179/mo

Semaglutide

$129/mo · first month

then $179/mo ongoing

Tirzepatide

$279/mo · first month

then $329/mo ongoing

Same price at every dose

Price checked on Amble’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

Get the $129/mo deal →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Amble is an Ohio-based telehealth platform that connects patients with licensed physicians for compounded semaglutide and tirzepatide at the same price at every dose, with medication, supplies, and shipping included. Month to month, semaglutide is $179 and tirzepatide $329, with $50 off the first month; 3- and 6-month plans paid upfront lower that to as little as $135 and $235 a month.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideSame price every doseFree shipping24/7 supportLegitScript VerifiedHSA/FSA on 3+ month plans

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

What is Amble?

Amble is an online platform from Amble Health, Inc. that connects you with state-licensed physicians who can prescribe compounded GLP-1 injections, with the same price at every dose. Plans include medication, supplies, shipping, and 24/7 messaging with your provider, and longer plans cost less per month. It suits people who want a flat, predictable price and are comfortable committing to a multi-month plan.

Vetted alternatives to Amble

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Amble logo
3.8 / 5
Our editorial rating
Visit Amble →

from $179/mo (after intro offer) · no insurance needed

Amble at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$179/mo (after intro offer) ($129 first month)
Pricing model
Flat: dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Amble

Each dimension is scored algorithmically from Amble’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.6/10

At $179/mo (after intro offer), Amble runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $129. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.8/10

Amble offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.5/10

Online intake and platform experience (ongoing clinician messaging, consult included in the price); 8 platform features disclosed.

Trust & Safety15%

7.0/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

8.4/10

Amble treats patients in all 50 states. FSA/HSA cards are accepted.

Support10%

6.1/10

Clinician messaging between visits.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Amble review

Last checked October 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$179–$329/mo across 2 dose/plan tiers (checked October 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Amble

We walked Amble’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1The GLP-1 product page shows a plan picker with per-month prices for 1-, 3- and 6-month plans before you start
  2. 2'Get started' opens Amble's intake, labeled as an 11-step questionnaire
  3. 3Step 1 asks 'Have you taken a GLP-1 medication before?'
Price shown before you start
  • Semaglutide and tirzepatide each have their own price table (semaglutide $179 month to month, tirzepatide $329), and a '$50 off first month' banner says the discount is auto-applied at checkout
  • The Terms say multi-month plans are charged upfront and can't be refunded once sent to the pharmacy, which the product pages don't mention
  • The FAQ says a video or audio visit is required only in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi
  • The homepage advertises 'Plans starting at $99 per month,' which doesn't match any GLP-1 plan shown

Amble customer support

GLP-1 medications Amble offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Month-to-month (1-month plan), same price every doseCompounded
$179$129/mo
Save 28% right now
semaglutide

$50 off first month, auto-applied at checkout. Longer plans, charged upfront: 3-month $160/mo, 6-month $135/mo. The site's mobile price table lists 6-month at $145/mo and adds a 12-month plan at $135/mo.

Month-to-month (1-month plan), same price every doseCompounded
$329$279/mo
Save 15% right now
tirzepatide

$50 off first month, auto-applied at checkout. Longer plans, charged upfront: 3-month $255/mo, 6-month $235/mo.

Ready to get started?

Plans and promotions change often, so check Amble's current pricing and active discounts before you decide.

See Amble pricing →

What we like

  • Same price at every dose, with medication, supplies, and shipping included
  • $50 off your first month, applied automatically at checkout
  • 3- and 6-month plans lower the monthly price (semaglutide as low as $135/mo, tirzepatide $235/mo)
  • Refund of your initial payment if a provider decides treatment isn't medically appropriate
  • Displays a LegitScript seal that links to its certification record
  • 4.5 stars from about 4,600 Trustpilot reviews
  • Unlimited 24/7 support included

Watch-outs

  • Longer plans are a firm commitment charged upfront, and no part is refundable once sent to the pharmacy
  • To stop a renewal, you must cancel at least 15 days before your next billing date
  • The homepage says 'Plans starting at $99 per month,' but no GLP-1 plan we found costs $99
  • Tirzepatide is pricey month to month at $329
  • Doesn't name its pharmacy partners or prescribing physicians
  • A short video or audio visit is required in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi
  • Strict billing terms: the Terms warn that customers who dispute charges may be sent to collections

Amble's pitch: one flat price that never climbs as your dose does

Amble is a straightforward, mainstream telehealth route to compounded GLP-1 medication, and its single most useful idea is right there in its own marketing: "same price, every dose." Most compounding programs quietly raise your bill as you titrate up to a higher milligram strength. Amble doesn't. Month to month, you pay $179 a month (after intro offer) for compounded semaglutide, starter dose or full maintenance dose alike, and that predictability is the main reason to consider it. If you've been burned by a program where month four cost noticeably more than month one, this is the antidote.

Is it worth it? For someone who wants no-drama online access to a GLP-1 without doing a lot of homework, often yes. Amble is deliberately simple. The flip side is that it's light on some public details and strict on billing, so read the Terms before you pick a longer plan.

How the pricing works

Amble uses flat, all-inclusive pricing rather than the dose-tiered ladders you'll see elsewhere. Compounded semaglutide is $179 a month (after intro offer) on a month-to-month plan, with $50 off your first month applied automatically at checkout, bringing month one to $129. Compounded tirzepatide, the dual-action molecule behind Mounjaro and Zepbound, is $329 a month month to month, or $279 for the first month with the same discount. For context, the median cheapest ongoing rate across the GLP-1 providers we track is about $179, so month-to-month semaglutide through Amble runs a touch above the middle of the pack, while tirzepatide at that price is on the expensive side.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

Longer plans cut the rate: 3- and 6-month plans bring semaglutide down to as little as $135 a month and tirzepatide to $235 a month. But the Terms say those plans are "a firm commitment to the full duration of the program," charged in full at purchase, and no part is refundable once the order is sent to the pharmacy. HSA and FSA cards are accepted on 3-month or longer plans. Also ignore the homepage line about plans "starting at $99 per month"; we found no GLP-1 plan at $99. Compare Bodi Envi, which also charges one price at every dose and says there are no long-term contracts.

The number that matters is what's bundled into it. Amble states that medication, supplies, and shipping are all included, plus the clinician consult, with no separate membership on top of the drug. Harmon.Health bundles the same pieces, with the visit, medication, supplies and free shipping in one monthly price. That helps when you compare quotes: a lower sticker price elsewhere can hide a separate consult fee, a shipping charge, or a supplies upcharge that Amble folds into the one figure.

  • Flat by design: the same monthly price holds as you titrate to higher doses
  • Bundled: medication, supplies, and shipping included in the quoted price
  • First-month discount: $50 off month one, auto-applied at checkout
  • Fine print to know: cancel renewals at least 15 days before your next billing date, or the cancellation may roll to the following cycle

The medications and how you get them

Amble offers both of the heavyweight GLP-1 options: semaglutide and tirzepatide. Having both under one roof matters because they're not interchangeable. Tirzepatide hits a second hormone receptor and tends to drive larger losses in trials, while semaglutide is the more established, lower-cost starting point. You can start on one and switch within the same program without re-onboarding somewhere new.

The process is fully online: an 11-step intake questionnaire, review by a licensed clinician, and a compounded GLP-1 shipped to your door with the supplies you need to inject. Most states need no live visit, but the FAQ says a short video or audio visit is required in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi. Unlimited 24/7 support is included.

What you're buying, and what to ask

Amble's medications are compounded, not the FDA-approved brand-name pens. Compounded GLP-1s are mixed by a pharmacy rather than manufactured by Lilly or Novo Nordisk, which is how the price stays low, but it also means the specific pharmacy and its sourcing matter. Amble displays a LegitScript seal that links to its certification record, and there are no FDA warning letters on file. It does not, however, name its pharmacy partners or prescribing physicians publicly.

So before you commit, ask Amble directly which compounding pharmacy fills your prescription and whether it's a state-licensed 503A or a 503B outsourcing facility.

Who should choose Amble, and who should skip it

Amble is a strong fit if you want both major GLP-1 options, value a price that won't creep upward as you increase your dose, and want a provider with a solid public track record: it holds 4.5 stars from about 4,600 Trustpilot reviews. It advertises availability in all 50 states, though it says exclusions apply without listing them, so confirm your state during intake. It's also a good pick for people who find most telehealth checkouts confusing and just want one number that covers everything. Another provider to compare is Genesis Health, which pairs its flat-priced compounded semaglutide and tirzepatide with health coaching and a member community, though it was named in a February 2026 FDA warning letter.

Skip it if you specifically need brand-name Wegovy, Ozempic, Mounjaro, or Zepbound; Amble's lane is compounded, and there's no brand-name pricing on file. Skip the longer plans if you might stop early, since they are non-refundable once the pharmacy has the order, and note that the Terms warn customers who dispute charges for orders already sent to the pharmacy may be sent to collections. Detail-oriented patients who want the exact compounding partner spelled out up front will find Amble's public information thinner than they'd like.

Bottom line

Amble does one thing unusually well: it removes dose-based pricing anxiety from a GLP-1 program. A flat, all-inclusive $179 a month (after intro offer) for compounded semaglutide that doesn't rise with your dose, both molecules available, and broad reach make it a sensible mainstream option. Just go in clear-eyed about the strict prepay and cancellation terms, and confirm the compounding pharmacy before your first shipment. Compare it against the field using our scoring methodology, and if simple, predictable pricing is what you're after, Amble is built around it.

The Bottom Line

Amble scores highest on state availability and ease of access.

Score: 7.5/10Best for: flat-price compounded GLP-1 with free shipping and discounts for 3- or 6-month plansFrom: $179/mo (after intro offer)

Ready to start with Amble?

From $179/mo (after intro offer). See current pricing and start your free consultation.

Amble might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Amble vs…

Amble scores7.5/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Amble Health, Inc. (Cortland, Ohio) is a telehealth platform that connects patients with state-licensed independent physicians and dispensing pharmacies through a fully online process. It displays a LegitScript seal linked to a certification record and has a 4.5-star Trustpilot rating from about 4,600 reviews. Amble does not name its pharmacy partners or prescribers on its site, and it describes itself as a managed services provider rather than a prescriber, with prescriptions written by independent physicians and filled by 503A and 503B pharmacies. Review its cancellation terms before enrolling, since longer plans are charged upfront and are non-refundable once sent to the pharmacy.
Yes. Amble's intake process requires a state-licensed physician to review your medical questionnaire and complete a full clinical evaluation before any prescription is issued. In some states (New Mexico, Kansas, West Virginia, Louisiana, and Mississippi), a short video or audio visit is also required rather than asynchronous review alone. Amble does not publicly name specific prescribers or a medical director. The company describes itself as a managed services provider that connects patients to independent licensed physicians, so your prescription comes from an independent clinician operating through Amble's platform. That is a common telehealth structure, and a licensed doctor still reviews your case before medication is issued.
Amble (Amble Health, Inc.) is a telehealth platform that connects patients with state-licensed physicians who can prescribe compounded semaglutide and tirzepatide for weight loss, using flat-rate pricing where your monthly cost stays the same regardless of dose. Plans bundle medication, supplies, shipping, and ongoing provider access via 24/7 messaging. Amble also offers NAD+, sermorelin, glutathione, and Lipo-B/C injections, plus a tirzepatide and NAD+ combination product.
Amble charges the same price at every dose. Compounded semaglutide is $179 a month on a 1-month plan and $160 a month on a 3-month plan; the 6-month plan is listed at $135 a month on the desktop page and $145 on the mobile page, which also shows a 12-month plan at $135 a month. Compounded tirzepatide is $329, $255, and $235 a month on 1-, 3-, and 6-month plans. A $50 first-month discount is applied automatically at checkout. Medication, supplies, and shipping are included. The Terms say longer plans are charged at the time of purchase. Always confirm current rates before enrolling.
Amble's compounded semaglutide and tirzepatide are not FDA-approved as finished products. That status applies to every telehealth provider offering compounded GLP-1 medications, not just Amble. The active ingredients are FDA-approved in brand-name form (Wegovy and Ozempic for semaglutide, Zepbound and Mounjaro for tirzepatide), but compounded versions sourced from 503A and 503B pharmacies do not carry individual FDA product approval. Amble discloses this on its FAQ page. If FDA-approved finished products are a priority, ask your Amble clinician about brand-name prescription options.
Amble offers programs using compounded semaglutide (the same active ingredient as Wegovy and Ozempic) and compounded tirzepatide (the same active ingredient as Zepbound and Mounjaro). Medications are dispensed by state-licensed 503A and 503B compounding pharmacies, though Amble does not publicly name specific pharmacy partners. Your clinician selects a starting dose based on your intake evaluation, and the flat-rate plan means your monthly cost does not increase as your dose escalates over time.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Amble. The concerns our review flags: Longer plans are a firm commitment charged upfront, and no part is refundable once sent to the pharmacy; To stop a renewal, you must cancel at least 15 days before your next billing date; The homepage says 'Plans starting at $99 per month,' but no GLP-1 plan we found costs $99; Tirzepatide is pricey month to month at $329. Weigh them before you sign up.
No. Amble doesn't require or use insurance; it charges a flat rate that includes medication, supplies, and shipping. HSA and FSA cards are accepted on 3-month and longer plans, and Amble provides itemized receipts if you want to submit them to your benefits provider.
Yes. You pay at checkout, and a licensed physician then reviews your intake. If the physician decides treatment isn't medically appropriate for you, Amble refunds your initial payment. Once an order goes to the pharmacy, it can't be canceled or refunded, and that includes every month a multi-month plan covers.
Amble doesn't name its pharmacies. It says prescriptions are filled by state-licensed U.S. pharmacies in its partner network, a mix of 503A compounding pharmacies overseen by state boards and 503B outsourcing facilities registered with the FDA.
No public promo code is listed on Amble's site. Its first-month discount is applied automatically at checkout, so there's no code to enter.
You can reach Amble's support team by email, and once you're a patient you can message your provider anytime through the patient portal. Requests to cancel future renewals can be sent by email or through your patient dashboard at least 15 days before your next billing date.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Amble review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Amble's current pricing

Plans from $179/mo (after intro offer). Start your free consultation to check eligibility and today's price.